Recombinant multi-species MYL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Myosin is a hexameric ATPase cellular motor protein. It is composed of two myosin heavy chains, two nonphosphorylatable myosin alkali light chains, and two phosphorylatable myosin regulatory light chains. This gene encodes a myosin alkali light chain that is found in embryonic muscle and adult atria. Two alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: MYL4,Myosin light chain 4,Myosin light chain 1, embryonic muscle/atrial isoform, Myosin light chain alkali GT-1 isoform,GT1,ALC1,AMLC,PRO1957

Target products collectionGo to MYL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2615-Ab-1/ GM-Tg-hg-IP2615-Ab-2 Human MYL4 protein Human
GM-Tg-rg-IP2615-Ab-1/ GM-Tg-rg-IP2615-Ab-2 Rat MYL4 protein Rat
GM-Tg-mg-IP2615-Ab-1/ GM-Tg-mg-IP2615-Ab-2 Mouse MYL4 protein Mouse
GM-Tg-cynog-IP2615-Ab-1/ GM-Tg-cynog-IP2615-Ab-2 Cynomolgus/Rhesus macaque MYL4 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2615-Ab-1/ GM-Tg-felg-IP2615-Ab-2 Feline MYL4 protein Feline
GM-Tg-cang-IP2615-Ab-1/ GM-Tg-cang-IP2615-Ab-2 Canine MYL4 protein Canine
GM-Tg-bovg-IP2615-Ab-1/ GM-Tg-bovg-IP2615-Ab-2 Bovine MYL4 protein Bovine
GM-Tg-equg-IP2615-Ab-1/ GM-Tg-equg-IP2615-Ab-2 Equine MYL4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2615-Ab-1/ GM-Tg-hg-IP2615-Ab-2; GM-Tg-rg-IP2615-Ab-1/ GM-Tg-rg-IP2615-Ab-2;
GM-Tg-mg-IP2615-Ab-1/ GM-Tg-mg-IP2615-Ab-2; GM-Tg-cynog-IP2615-Ab-1/ GM-Tg-cynog-IP2615-Ab-2;
GM-Tg-felg-IP2615-Ab-1/ GM-Tg-felg-IP2615-Ab-2; GM-Tg-cang-IP2615-Ab-1/ GM-Tg-cang-IP2615-Ab-2;
GM-Tg-bovg-IP2615-Ab-1/ GM-Tg-bovg-IP2615-Ab-2; GM-Tg-equg-IP2615-Ab-1/ GM-Tg-equg-IP2615-Ab-2
Products Name MYL4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MYL4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYL4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.